New insights and new therapies in vitiligo.
Grimes
Pearl E
PE
Vitiligo and Pigmentation Institute of Southern California, Los Angeles, USA. pegrimesmd@earthlink.net
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017690:Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008544:Melanocytes / Q000637:transplantation; D010789:Phototherapy; D016038:Skin Transplantation; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014820:Vitiligo / Q000209:etiology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; C055085:calcipotriene; C117268:pimecrolimus; D002117:Calcitriol; D016559:Tacrolimus